Literature DB >> 17556800

Cytotoxic activity of the selected pyridinium salts against murine leukemia L1210.

Marzena Wieczorkowska1, Piotr Szajerski, Radosław Michalski, Jan Adamus, Andrzej Marciniak, Jerzy Gebicki, Ewa Ciesielska, Leszek Szmigiero, Ewa Lech-Marańda, Anna Szmigielska-Kapłon, Tadeusz Robak.   

Abstract

The objective of this work was to evaluate the relationship between chemical reactivity of 3-substituted pyridinium salts and their cytotoxic properties against murine leukemia L1210. Chemical reactivity of pyridinium salts towards NADH oxidation following one-step hydride transfer depends strongly on their redox properties. The investigated reaction may reflect the ability of the salts to deplete NADH level in cells and to affect their metabolic functions. On the other hand, the cytotoxic activity against murine leukemia cells, expressed as ED50 values, varied strongly depending upon the compound used. The investigated salts showed also a diverse antileukemic effect in in vivo experiments as measured by the increase in the survival time of L1210 leukemia-bearing mice. These biological effects were correlated with equilibrium constants found for the reaction of pyridinium salts with NADH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556800

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis.

Authors:  Agnieszka Blazejczyk; Marta Switalska; Stefan Chlopicki; Andrzej Marcinek; Jerzy Gebicki; Marcin Nowak; Anna Nasulewicz-Goldeman; Joanna Wietrzyk
Journal:  J Exp Clin Cancer Res       Date:  2016-07-13

2.  Antitumour Effects of Selected Pyridinium Salts on Sensitive Leukaemia HL60 Cells and Their Multidrug Resistant Topoisomerase II-Defective HL60/MX2 Counterparts.

Authors:  Jolanta Tarasiuk; Dorota Kostrzewa-Nowak; Wojciech Żwierełło
Journal:  Molecules       Date:  2022-08-12       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.